A 24 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Allium fistulosum L. root extract on improvement of child height growth

Daejeon Korean Medicine Hospital of Daejeon University0 个研究点目标入组 100 人开始时间: 待定最近更新: 2021年3月22日

试验速览

暂无简介。

•1) Children before adolescence, 3~ 25 percentile based on 2017 Korea standard growth chart percentile
•2) Spontaneously agreed to participate in the study by the patients and legal guardians or parents

•1) Participants who have taken Hormone replacement therapy or calcitonin, Phosphonate, growth hormone within 6 month prior to the screening examination
•2) Participants with a clinically significant disease requiring treatment (i.e., acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
•3) Participants who take medicine or health functional food for improvement of child height growth within 3 month prior to the screening examination
•4) Participants with a history of antipsychotic medication use within 3 months prior to the screening examination
•5) Participantts who have participated in other clinical trials within 3 months prior to the screening examination
•6) Participants who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes

发起方

Daejeon Korean Medicine Hospital of Daejeon University